| Literature DB >> 9816522 |
D P Lee1, S Lo, K M Forster, D J Tate, A Raizner, S N Oesterle.
Abstract
The Proliferation REduction with Vascular ENergy Trial (PREVENT) is a prospective randomized study of the safety and efficacy of intracoronary brachytherapy to reduce restenosis. A beta-emitter, 32P, is embedded on a wire tip and delivered to the target site through a centering catheter immediately following a coronary intervention. The radiation doses are 16, 20, and 24 Gy measured at 1 mm within the vessel wall. Follow-up includes an angiogram and IVUS at 6 months. Phase I of this trial has been completed with results expected in early 1999.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9816522 DOI： 10.1007/bf03043601
Source DB: PubMed Journal: Herz ISSN： 0340-9937 Impact factor: 1.443